Is this imminent FDA feedback on the interim results from the mono therapy study or on the design protocol for the upcoming combined study with JAK inhibitor?
Ann: Investor Presentation, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $31.04M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.8¢ | 2.5¢ | $45.27K | 1.734M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121728 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 148236 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| SNT (ASX) Chart |